Evaluate The Cooper Companies' (COO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
The Cooper Companies (COO) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $0.96 per share a year ago.
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both The Cooper Companies (COO) and Straumann Holding AG (SAUHY). But which of these two stocks is more attractive to value investors?
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Albert G. White CEO | XSTU Exchange | US2166485019 ISIN |
| US Country | 16,000 Employees | 11 Aug 2023 Last Dividend | 20 Feb 2024 Last Split | - IPO Date |
The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global entity that specializes in the development, manufacture, and marketing of contact lenses through its subsidiaries. The operations of the company are segmented into CooperVision and CooperSurgical. CooperVision focuses on providing a variety of contact lenses including those for correcting nearsightedness, farsightedness, astigmatism, presbyopia, and myopia across various regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical addresses family and women's health, offering a wide range of fertility products and services, medical devices, contraception, and cryostorage services for cord blood and tissue to healthcare professionals and patients globally. The products offered by The Cooper Companies, Inc. reach their end-users through distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals, clinics, and authorized resellers.
CooperVision:
CooperSurgical: